60 related articles for article (PubMed ID: 20405921)
1. Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors.
León LG; Ríos-Luci C; Tejedor D; Pérez-Roth E; Montero JC; Pandiella A; García-Tellado F; Padrón JM
J Med Chem; 2010 May; 53(9):3835-9. PubMed ID: 20405921
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
3. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
4. From DNA damage to G2 arrest: the many roles of topoisomerase II.
Larsen AK; Escargueil AE; Skladanowski A
Prog Cell Cycle Res; 2003; 5():295-300. PubMed ID: 14593724
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking studies of the interaction between propargylic enol ethers and human DNA topoisomerase IIα.
Silveira-Dorta G; Sousa IJ; Ríos-Luci C; Martín VS; Fernandes MX; Padrón JM
Bioorg Med Chem Lett; 2013 Oct; 23(19):5382-4. PubMed ID: 23953196
[TBL] [Abstract][Full Text] [Related]
6. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of ICRF-193 influence on cell passage through mitosis].
Shatrova A; Aksenov ND; Zenin VV
Tsitologiia; 2002; 44(11):1068-78. PubMed ID: 12561727
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 164. Podophenazine, 2'',3''-dichloropodophenazine, benzopodophenazine, and their 4 beta-p-nitroaniline derivatives as novel DNA topoisomerase II inhibitors.
Cho SJ; Kashiwada Y; Bastow KF; Cheng YC; Lee KH
J Med Chem; 1996 Mar; 39(7):1396-402. PubMed ID: 8691469
[TBL] [Abstract][Full Text] [Related]
9. Thanatop: a novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase II.
Polycarpou-Schwarz M; Müller K; Denger S; Riddell A; Lewis J; Gannon F; Reid G
Cancer Res; 2007 May; 67(9):4451-8. PubMed ID: 17483360
[TBL] [Abstract][Full Text] [Related]
10. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
[TBL] [Abstract][Full Text] [Related]
11. Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals. Evidence for the essential contribution of the enzyme to chromosome segregation.
Pastor N; Cantero G; Campanella C; Cortés F
Mutat Res; 2005 Apr; 582(1-2):11-9. PubMed ID: 15781205
[TBL] [Abstract][Full Text] [Related]
12. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerase II by imidazoacridinones, new antineoplastic agents with strong activity against solid tumors.
Skladanowski A; Plisov SY; Konopa J; Larsen AK
Mol Pharmacol; 1996 May; 49(5):772-80. PubMed ID: 8622625
[TBL] [Abstract][Full Text] [Related]
14. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
Han S; Xiao Z; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction pathways leading to cell cycle arrest and apoptosis induced by DNA topoisomerase poisons.
Andoh T
Cell Biochem Biophys; 2000; 33(2):181-8. PubMed ID: 11325038
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
Sullivan DM; Eskildsen LA; Groom KR; Webb CD; Latham MD; Martin AW; Wellhausen SR; Kroeger PE; Rowe TC
Mol Pharmacol; 1993 Feb; 43(2):207-16. PubMed ID: 8094226
[TBL] [Abstract][Full Text] [Related]
19. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
[TBL] [Abstract][Full Text] [Related]
20. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay].
Shatrova AN; Aksenov ND; Poletaev AI; Zenin VV
Tsitologiia; 2003; 45(1):59-68. PubMed ID: 12683237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]